Nifty

:

25571.25

Sensex

:

82814.71

116.90 (0.46%)
316.57 (0.38%)

Login

Nifty
Sensex

:
:

25571.25
82814.71

116.90 (0.46%)
316.57 (0.38%)

Ind-Swift Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

62/99

BSE: 532305 | NSE: INDSWFTLAB

Watchlist

NSE BSE

141.89

20-Feb-2026

Open
High
Low
Previous Close

138.32
146.69
137.36
137.53

Volume
Traded Value (lacs)
52 Week High
52 Week Low

777539
111291633.58
149.9
68.72

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,154.40
4.64
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

776.30
N/A
0.88

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-1.50
-8.82
-22.51

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
73.67

P:E (Median)

8 Years
5 Years
3 Years

3.75
3.51
3.50

P:BV (Average)

8 Years
5 Years
3 Years

0.84
0.87
0.81

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.34
4.98
4.12

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 149.48 121.54 22.99% 150.44 139.05 8.19% 148.00 144.31 2.56% 144.75 516.96 -72.00%
Expenses 144.08 122.47 17.65% 148.25 136.32 8.75% 144.92 145.58 -0.45% 158.21 429.77 -63.19%
EBITDA 5.40 -0.93 - 2.19 2.73 -19.78% 3.07 -1.27 - -13.47 87.20 -
EBIDTM 3.61% -0.77% 1.46% 1.97% 2.08% -0.88% -9.30% 16.87%
Other Income 27.58 16.63 65.84% 17.86 17.16 4.08% 14.58 43.07 -66.15% 4.41 71.26 -93.81%
Interest 0.67 10.03 -93.32% 2.01 9.94 -79.78% 1.15 9.71 -88.16% -26.76 2.95 -
Depreciation 8.83 5.81 51.98% 6.98 5.61 24.42% 6.68 5.62 18.86% 7.44 19.55 -61.94%
PBT 17.62 -0.86 - 11.05 4.43 149.44% 9.82 34.43 -71.48% 226.15 522.92 -56.75%
Tax 6.87 0.00 0 2.30 0.00 0 1.71 0.00 0 8.06 32.24 -75.00%
PAT 10.74 -0.86 - 8.75 4.43 97.52% 8.12 34.43 -76.42% 218.09 490.69 -55.55%
PATM 7.19% -0.71% 5.82% 3.19% 5.49% 23.86% 150.67% 94.92%
EPS 1.32 -0.11 - 1.07 0.54 98.15% 0.99 4.22 -76.54% 26.73 60.13 -55.55%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 150.85 128.80 17.12% 152.64 148.30 2.93% 152.73 147.02 3.88% 138.24 528.57 -73.85%
Expenses 146.68 135.45 8.29% 151.17 145.37 3.99% 149.13 153.50 -2.85% 147.43 437.36 -66.29%
EBITDA 4.18 -6.65 - 1.47 2.94 -50.00% 3.60 -6.48 - -9.20 91.21 -
EBIDTM 2.77% -5.16% 0.97% 1.98% 2.36% -4.41% -6.65% 17.26%
Other Income 27.58 16.64 65.75% 17.86 17.22 3.72% 14.58 43.07 -66.15% 4.46 71.26 -93.74%
Interest 0.67 10.03 -93.32% 2.01 9.94 -79.78% 1.15 9.71 -88.16% -26.76 2.96 -
Depreciation 8.83 5.81 51.98% 6.98 5.61 24.42% 6.68 5.62 18.86% 7.44 19.55 -61.94%
PBT 16.39 -6.58 - 10.34 4.70 120.00% 10.35 29.22 -64.58% 230.46 526.93 -56.26%
Tax 6.87 -1.08 - 2.30 0.18 1,177.78% 1.71 -0.03 - 8.19 33.14 -75.29%
PAT 9.52 -5.50 - 8.04 4.51 78.27% 8.65 29.25 -70.43% 222.27 493.79 -54.99%
PATM 6.31% -4.27% 5.27% 3.04% 5.66% 19.89% 160.79% 93.42%
EPS 1.17 -0.93 - 0.98 0.67 46.27% 1.28 4.34 -70.51% 32.33 73.45 -55.98%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 592.67 549.65 1,227.32 1,151.96 988.09 856.58 751.84 724.43 728.33 674.90 638.74 Net Sales Growth -35.71% -55.22% 6.54% 16.58% 15.35% 13.93% 3.78% -0.54% 7.92% 5.66% Cost Of Goods Sold 288.55 285.00 623.58 616.84 498.15 424.99 378.85 379.33 372.09 377.00 344.31 Gross Profit 304.12 264.65 603.74 535.12 489.93 431.58 372.99 345.10 356.23 297.91 294.44 GP Margin 51.31% 48.15% 49.19% 46.45% 49.58% 50.38% 49.61% 47.64% 48.91% 44.14% 46.10% Total Expenditure 595.46 562.59 977.35 929.86 794.38 676.10 610.78 599.15 601.53 569.87 532.05 Power & Fuel Cost - 13.72 61.43 76.07 58.40 37.31 34.65 37.44 29.58 26.00 22.65 % Of Sales - 2.50% 5.01% 6.60% 5.91% 4.36% 4.61% 5.17% 4.06% 3.85% 3.55% Employee Cost - 103.67 137.59 123.03 114.92 95.47 93.58 88.94 85.22 67.53 60.74 % Of Sales - 18.86% 11.21% 10.68% 11.63% 11.15% 12.45% 12.28% 11.70% 10.01% 9.51% Manufacturing Exp. - 36.88 45.50 43.41 40.85 64.24 59.30 50.06 63.50 43.40 38.56 % Of Sales - 6.71% 3.71% 3.77% 4.13% 7.50% 7.89% 6.91% 8.72% 6.43% 6.04% General & Admin Exp. - 60.87 49.56 33.35 30.18 23.56 23.77 22.89 24.07 19.96 19.33 % Of Sales - 11.07% 4.04% 2.90% 3.05% 2.75% 3.16% 3.16% 3.30% 2.96% 3.03% Selling & Distn. Exp. - 60.80 36.70 35.74 37.95 28.74 20.24 20.41 27.00 28.12 27.89 % Of Sales - 11.06% 2.99% 3.10% 3.84% 3.36% 2.69% 2.82% 3.71% 4.17% 4.37% Miscellaneous Exp. - 1.65 22.98 1.42 13.93 1.77 0.40 0.07 0.06 7.86 27.89 % Of Sales - 0.30% 1.87% 0.12% 1.41% 0.21% 0.05% 0.01% 0.01% 1.16% 2.91% EBITDA -2.81 -12.94 249.97 222.10 193.71 180.48 141.06 125.28 126.80 105.03 106.69 EBITDA Margin -0.47% -2.35% 20.37% 19.28% 19.60% 21.07% 18.76% 17.29% 17.41% 15.56% 16.70% Other Income 64.43 81.27 45.31 33.28 42.50 23.13 36.08 47.00 25.70 22.62 15.91 Interest -22.93 2.92 51.10 92.17 95.55 100.20 106.65 92.24 35.36 90.25 106.41 Depreciation 29.93 24.48 53.30 57.36 130.97 87.29 90.06 104.05 86.62 88.26 84.75 PBT 264.64 40.94 190.88 105.85 9.69 16.12 -19.56 -24.01 30.52 -50.85 -68.55 Tax 18.94 8.06 159.08 36.73 13.70 20.52 1.23 20.35 10.96 -16.46 -24.28 Tax Rate 7.16% 3.05% 27.55% 46.38% 171.25% 127.30% -6.29% 34.53% 38.35% 29.29% 29.21% PAT 245.70 256.09 418.39 42.47 -5.71 -4.40 -20.79 38.58 17.62 -39.73 -58.86 PAT before Minority Interest 245.70 256.09 418.39 42.47 -5.71 -4.40 -20.79 38.58 17.62 -39.73 -58.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 41.46% 46.59% 34.09% 3.69% -0.58% -0.51% -2.77% 5.33% 2.42% -5.89% -9.22% PAT Growth -53.53% -38.79% 885.14% - - - - 118.96% - - EPS 30.11 31.38 51.27 5.20 -0.70 -0.54 -2.55 4.73 2.16 -4.87 -7.21

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 594.46 561.71 1,280.90 1,207.31 1,038.73 891.34 779.64 756.60 762.52 697.42 653.25 Net Sales Growth -37.60% -56.15% 6.10% 16.23% 16.54% 14.33% 3.05% -0.78% 9.33% 6.76% Cost Of Goods Sold 278.68 287.95 661.46 655.59 537.43 451.44 396.66 403.36 390.56 392.19 353.01 Gross Profit 315.78 273.76 619.44 551.73 501.30 439.90 382.98 353.24 371.96 305.24 300.23 GP Margin 53.12% 48.74% 48.36% 45.70% 48.26% 49.35% 49.12% 46.69% 48.78% 43.77% 45.96% Total Expenditure 594.41 581.10 1,026.69 978.11 843.11 708.54 636.16 630.48 628.43 591.47 545.97 Power & Fuel Cost - 13.72 61.43 76.07 58.45 37.31 34.65 37.44 29.58 26.00 22.65 % Of Sales - 2.44% 4.80% 6.30% 5.63% 4.19% 4.44% 4.95% 3.88% 3.73% 3.47% Employee Cost - 105.85 141.52 126.17 117.40 97.86 95.92 90.98 88.12 69.65 62.76 % Of Sales - 18.84% 11.05% 10.45% 11.30% 10.98% 12.30% 12.02% 11.56% 9.99% 9.61% Manufacturing Exp. - 36.88 45.50 43.41 40.85 64.24 59.30 50.06 63.50 43.40 38.56 % Of Sales - 6.57% 3.55% 3.60% 3.93% 7.21% 7.61% 6.62% 8.33% 6.22% 5.90% General & Admin Exp. - 74.24 55.12 38.17 36.03 27.17 27.58 27.27 28.69 23.33 21.54 % Of Sales - 13.22% 4.30% 3.16% 3.47% 3.05% 3.54% 3.60% 3.76% 3.35% 3.30% Selling & Distn. Exp. - 60.81 38.68 37.29 39.03 28.74 21.65 21.30 27.92 29.06 28.87 % Of Sales - 10.83% 3.02% 3.09% 3.76% 3.22% 2.78% 2.82% 3.66% 4.17% 4.42% Miscellaneous Exp. - 1.65 22.98 1.42 13.93 1.77 0.40 0.07 0.06 7.86 28.87 % Of Sales - 0.29% 1.79% 0.12% 1.34% 0.20% 0.05% 0.01% 0.01% 1.13% 2.84% EBITDA 0.05 -19.39 254.21 229.20 195.62 182.80 143.48 126.12 134.09 105.95 107.28 EBITDA Margin 0.01% -3.45% 19.85% 18.98% 18.83% 20.51% 18.40% 16.67% 17.59% 15.19% 16.42% Other Income 64.48 81.38 45.37 33.50 43.50 22.71 33.46 36.91 25.82 22.62 15.91 Interest -22.93 2.92 51.10 92.17 95.55 100.22 106.65 92.24 35.38 90.27 106.42 Depreciation 29.93 24.48 53.30 57.36 131.04 87.29 90.06 104.05 86.62 88.26 84.75 PBT 267.54 34.59 195.17 113.17 12.53 18.01 -19.77 -33.26 37.92 -49.96 -67.98 Tax 19.07 7.27 160.31 38.69 14.68 21.16 1.42 20.73 14.01 -16.17 -24.09 Tax Rate 7.13% 2.82% 27.56% 44.72% 117.16% 117.49% -7.18% 41.73% 38.94% 29.24% 29.10% PAT 248.48 250.53 421.45 47.83 -2.15 -3.15 -21.19 28.95 21.98 -39.13 -58.69 PAT before Minority Interest 248.48 250.53 421.45 47.83 -2.15 -3.15 -21.19 28.95 21.98 -39.13 -58.69 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 41.80% 44.60% 32.90% 3.96% -0.21% -0.35% -2.72% 3.83% 2.88% -5.61% -8.98% PAT Growth -52.40% -40.56% 781.14% - - - - 31.71% - - EPS 30.45 30.70 51.65 5.86 -0.26 -0.39 -2.60 3.55 2.69 -4.80 -7.19

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,164.08 922.24 675.35 632.56 638.69 644.61 590.29 543.37 525.88 514.69 Share Capital 68.74 59.09 59.81 59.81 59.81 59.81 48.29 46.00 45.46 41.68 Total Reserves 1,021.24 863.16 615.54 572.75 578.89 584.80 542.00 495.82 477.95 473.01 Non-Current Liabilities -3.01 -27.62 733.03 806.37 832.95 828.33 901.32 437.80 494.76 717.24 Secured Loans 3.21 3.00 744.43 839.07 875.41 885.96 953.86 503.97 563.69 666.84 Unsecured Loans 19.33 0.00 0.00 0.00 0.00 4.93 11.72 16.52 28.32 79.48 Long Term Provisions 11.37 1.23 17.79 17.03 15.73 14.76 14.34 13.32 9.16 0.00 Current Liabilities 216.35 178.32 350.05 313.61 286.71 309.29 342.34 919.84 994.23 949.20 Trade Payables 110.46 63.91 193.13 163.32 123.96 127.12 115.70 116.58 94.95 129.45 Other Current Liabilities 94.71 10.95 96.03 81.47 89.49 99.23 134.13 491.94 493.59 316.09 Short Term Borrowings 5.27 2.57 49.02 63.86 72.58 82.94 92.52 311.31 405.70 503.66 Short Term Provisions 5.91 100.89 11.87 4.96 0.69 0.00 0.00 0.00 0.00 0.00 Total Liabilities 1,377.42 1,072.94 1,758.43 1,752.54 1,758.35 1,782.23 1,833.95 1,901.01 2,014.87 2,181.13 Net Block 270.71 5.32 585.00 626.79 737.64 842.93 900.99 924.38 1,032.35 1,098.52 Gross Block 651.65 7.38 1,330.13 1,315.21 1,298.09 1,355.90 1,378.74 1,349.06 1,406.63 1,420.29 Accumulated Depreciation 380.94 2.06 745.13 688.42 560.45 512.97 477.75 424.68 374.28 321.78 Non Current Assets 583.69 527.41 684.35 754.37 892.55 937.66 1,016.66 1,095.57 1,210.47 1,272.28 Capital Work in Progress 0.00 0.00 7.71 10.31 18.84 11.45 19.87 68.60 70.26 78.47 Non Current Investment 229.55 165.94 85.12 110.68 55.33 26.36 38.88 39.12 39.35 26.38 Long Term Loans & Adv. 81.17 353.84 4.10 3.89 65.97 56.92 56.92 63.48 54.21 68.92 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 14.31 0.00 Current Assets 793.73 545.54 1,072.67 996.15 865.80 844.56 817.29 805.44 804.41 908.85 Current Investments 39.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 107.25 0.00 427.54 414.00 354.41 342.82 316.61 316.91 343.56 356.02 Sundry Debtors 160.23 106.60 469.49 428.35 400.15 384.66 333.47 382.82 340.82 358.82 Cash & Bank 413.01 425.73 9.96 9.38 9.95 8.84 29.09 6.43 14.21 21.43 Other Current Assets 73.88 0.00 9.02 16.92 101.29 108.24 138.12 99.27 105.81 172.58 Short Term Loans & Adv. 69.94 13.21 156.66 127.51 42.66 69.51 96.30 86.22 89.49 159.33 Net Current Assets 577.38 367.22 722.63 682.54 579.09 535.27 474.95 -114.40 -189.83 -40.35 Total Assets 1,377.42 1,072.95 1,757.02 1,750.52 1,758.35 1,782.22 1,833.95 1,901.01 2,014.88 2,181.13

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,173.00 931.46 681.93 600.97 603.51 640.64 587.81 553.24 531.32 517.43 Share Capital 68.74 59.09 59.81 59.81 59.81 59.81 48.29 46.00 45.46 41.68 Total Reserves 1,030.16 872.37 622.12 541.17 543.70 580.83 539.53 505.69 483.39 475.74 Non-Current Liabilities 0.15 -19.46 741.18 813.57 840.15 828.33 901.32 437.80 494.76 717.24 Secured Loans 6.38 11.16 752.60 847.78 884.13 885.96 953.86 503.97 563.69 666.84 Unsecured Loans 19.33 0.00 0.00 0.00 0.00 4.93 11.72 16.52 28.32 79.48 Long Term Provisions 11.37 1.23 17.79 17.03 15.73 14.76 14.34 13.32 9.16 0.00 Current Liabilities 220.58 221.28 371.09 334.47 314.52 323.07 356.00 935.93 1,005.02 950.81 Trade Payables 110.23 93.98 203.99 175.95 138.82 135.23 126.68 128.64 102.36 132.43 Other Current Liabilities 98.75 22.80 105.67 89.10 81.29 72.92 136.49 490.25 496.93 314.60 Short Term Borrowings 5.55 2.71 49.17 64.03 93.43 114.93 92.52 311.31 405.70 503.66 Short Term Provisions 6.04 101.79 12.25 5.39 0.98 0.00 0.31 5.73 0.03 0.12 Total Liabilities 1,393.70 1,133.26 1,794.20 1,748.90 1,758.09 1,792.04 1,845.13 1,926.97 2,031.10 2,185.48 Net Block 260.07 5.36 585.04 627.53 738.65 843.14 901.20 924.59 1,032.56 1,098.73 Gross Block 568.16 8.15 1,330.90 1,316.68 1,302.04 1,359.32 1,378.95 1,349.27 1,406.84 1,420.51 Accumulated Depreciation 308.09 2.79 745.86 689.15 563.38 516.18 477.75 424.68 374.28 321.78 Non Current Assets 528.35 472.13 629.68 673.56 813.91 929.00 1,009.05 1,087.71 1,202.46 1,263.78 Capital Work in Progress 10.68 0.00 7.71 10.31 18.84 11.45 19.87 68.60 70.26 78.47 Non Current Investment 174.09 110.54 30.34 29.06 35.53 17.45 31.03 31.02 31.09 17.63 Long Term Loans & Adv. 81.25 353.92 4.17 3.96 6.11 56.95 56.95 63.50 54.24 68.96 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 14.31 0.00 Current Assets 865.35 661.13 1,163.12 1,073.32 941.88 863.03 836.09 839.26 828.64 921.70 Current Investments 39.37 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 114.18 10.46 438.60 428.50 375.67 342.82 316.61 316.91 343.56 356.02 Sundry Debtors 164.52 169.12 505.32 454.78 432.39 396.45 350.85 407.76 357.27 372.45 Cash & Bank 428.04 431.93 18.20 21.48 11.60 10.58 29.97 9.45 16.13 22.58 Other Current Assets 119.25 0.00 9.02 16.92 122.23 113.18 138.66 105.14 111.69 170.66 Short Term Loans & Adv. 115.31 49.62 191.98 151.64 65.90 74.45 96.84 92.09 95.37 157.41 Net Current Assets 644.77 439.85 792.03 738.86 627.36 539.96 480.08 -96.67 -176.37 -29.11 Total Assets 1,393.70 1,133.26 1,792.80 1,746.88 1,755.79 1,792.03 1,845.14 1,926.97 2,031.10 2,185.48

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -39.15 -179.77 182.67 136.26 135.03 123.16 -74.63 71.46 92.67 80.44 PBT 40.94 190.88 105.85 9.69 16.12 -19.56 -24.01 30.52 -50.85 -68.55 Adjustment -40.26 124.76 132.78 225.59 179.35 176.02 176.17 103.64 167.95 186.52 Changes in Working Capital -39.83 -495.41 -55.95 -99.02 -60.43 -33.30 -226.79 -62.70 -24.43 -37.53 Cash after chg. in Working capital -39.15 -179.77 182.67 136.26 135.03 123.16 -74.63 71.46 92.67 80.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -109.67 -104.32 -13.69 2.76 -10.17 -10.15 -2.34 -17.25 -30.99 -29.56 Net Fixed Assets -644.27 1,330.46 -12.32 -8.59 50.42 31.26 19.05 59.23 21.87 18.07 Net Investments -102.98 -80.82 25.56 -55.35 -28.97 12.52 0.24 0.23 -12.97 -0.05 Others 637.58 -1,353.96 -26.93 66.70 -31.62 -53.93 -21.63 -76.71 -39.89 -47.58 Cash from Financing Activity 74.22 699.86 -168.41 -139.59 -123.75 -133.26 99.62 -61.98 -68.90 -47.92 Net Cash Inflow / Outflow -74.60 415.77 0.58 -0.57 1.11 -20.25 22.66 -7.78 -7.22 2.95 Opening Cash & Equivalents 487.62 9.96 9.38 9.95 8.84 29.09 6.43 14.21 21.43 18.48 Closing Cash & Equivalent 413.01 425.73 9.96 9.38 9.95 8.84 29.09 6.43 14.21 21.43

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -25.47 -163.12 194.62 150.27 134.95 125.24 -64.40 73.09 95.57 79.43 PBT 34.59 195.17 113.17 12.53 18.01 -19.77 -33.26 37.87 -49.96 -67.98 Adjustment -40.31 124.76 132.78 225.66 179.35 176.02 186.26 103.64 167.95 186.30 Changes in Working Capital -19.76 -483.05 -51.33 -87.92 -62.41 -31.01 -214.80 -68.41 -22.42 -38.89 Cash after chg. in Working capital -25.47 -163.12 194.62 150.27 134.95 125.24 -61.80 73.09 95.57 79.43 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 -2.60 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -109.62 -104.32 -13.37 4.77 -10.17 -9.10 -12.47 -17.40 -30.94 -29.56 Net Fixed Assets -644.27 1,330.46 -12.32 -8.59 50.42 31.26 19.05 59.23 21.87 18.07 Net Investments -102.98 -80.82 25.56 -55.35 -28.97 12.52 0.24 0.23 -12.97 -0.05 Others 637.63 -1,353.96 -26.61 68.71 -31.62 -52.88 -31.76 -76.86 -39.84 -47.58 Cash from Financing Activity 69.20 680.71 -185.66 -140.88 -123.75 -133.26 99.62 -61.98 -68.90 -47.92 Net Cash Inflow / Outflow -65.89 413.28 -4.41 14.17 1.03 -17.12 22.76 -6.30 -4.27 1.94 Opening Cash & Equivalents 493.93 18.20 21.48 11.60 10.58 29.97 9.45 16.13 22.58 19.84 Closing Cash & Equivalent 427.46 431.93 18.20 25.77 11.61 10.58 29.97 9.45 16.13 21.78

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 158.56 156.08 83.14 73.68 72.30 70.88 73.53 63.40 56.86 56.11 ROA 20.90% 29.55% 2.42% -0.33% -0.25% -1.15% 2.07% 0.90% -1.89% -2.67% ROE 25.45% 59.20% 9.17% -1.32% -1.04% -5.41% 12.12% 6.51% -16.41% -23.42% ROCE 25.18% 55.54% 12.67% 7.47% 8.24% 6.04% 10.65% 4.45% 2.14% 1.38% Fixed Asset Turnover 1.71 1.85 0.87 0.76 0.65 0.55 0.53 0.53 0.49 0.47 Receivable days 86.31 85.06 141.60 151.57 165.89 173.48 179.63 179.41 184.06 203.30 Inventory Days 69.38 0.00 132.72 140.57 147.38 159.30 158.87 163.74 184.04 195.15 Payable days 111.66 75.23 105.46 105.24 107.82 65.88 60.20 57.51 63.08 84.37 Cash Conversion Cycle 44.04 9.83 168.86 186.90 205.45 266.90 278.30 285.64 305.03 314.08 Total Debt/Equity 0.03 0.01 1.72 2.14 2.28 2.38 3.18 3.76 4.87 6.32 Interest Cover 91.51 12.30 1.86 1.08 1.16 0.82 1.64 1.81 0.38 0.22

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 159.86 157.64 84.25 68.33 66.35 70.21 73.01 65.58 58.08 56.78 ROA 19.83% 28.79% 2.70% -0.12% -0.18% -1.17% 1.53% 1.11% -1.86% -2.65% ROE 24.68% 58.97% 10.61% -0.54% -0.78% -5.56% 8.99% 7.89% -15.89% -23.11% ROCE 24.24% 55.13% 13.25% 7.88% 8.31% 5.97% 9.25% 4.59% 2.19% 1.40% Fixed Asset Turnover 2.00 1.93 0.92 0.80 0.67 0.57 0.56 0.56 0.51 0.48 Receivable days 105.66 95.44 144.51 154.46 168.41 174.12 182.19 181.25 185.94 206.44 Inventory Days 39.47 63.55 130.51 140.01 145.99 153.65 152.15 156.48 178.26 190.95 Payable days 129.43 82.21 105.77 106.89 110.78 68.85 63.73 60.79 64.19 12.73 Cash Conversion Cycle 15.71 76.78 169.25 187.58 203.62 258.91 270.60 276.94 300.00 384.67 Total Debt/Equity 0.03 0.01 1.71 2.33 2.56 2.48 3.21 4.38 4.77 6.25 Interest Cover 89.31 12.38 1.94 1.13 1.18 0.81 1.54 2.02 0.39 0.22

Top Investors:

hcp investments

zeal global opportunities fund

ashokkumar chandak

panchkula finvest private limited

sharwan singh guleria

investor education and protection fund (iepf)

Annual Reports:

News Update:

Ind-Swift Laboratories to upgrade Samba facility with investment of Rs 40 crore
16th Feb 2026, 15:42 PM

The facility will be enhanced to meet international regulatory standards, primarily EU-GMP and PIC/S, enabling the site to cater to regulated export markets
Read More
Ind-Swift Lab. - Quarterly Results
1st Feb 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback